202 related articles for article (PubMed ID: 25594028)
1. The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population.
Lubanska D; Porter LA
Oncoscience; 2014; 1(5):336-48. PubMed ID: 25594028
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
[TBL] [Abstract][Full Text] [Related]
3. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.
Ferraiuolo RM; Fifield BA; Hamm C; Porter LA
Breast Cancer Res Treat; 2022 Nov; 196(1):17-30. PubMed ID: 36029387
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.
Lubanska D; Market-Velker BA; deCarvalho AC; Mikkelsen T; Fidalgo da Silva E; Porter LA
Cancer Cell; 2014 Jan; 25(1):64-76. PubMed ID: 24434210
[TBL] [Abstract][Full Text] [Related]
6. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
Cheng A; Xiong W; Ferrell JE; Solomon MJ
Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
[TBL] [Abstract][Full Text] [Related]
7. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
[TBL] [Abstract][Full Text] [Related]
8. Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.
Al Sorkhy M; Fifield BA; Myers D; Porter LA
Cell Cycle; 2016; 15(1):128-36. PubMed ID: 26771716
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Al Sorkhy M; Ferraiuolo RM; Jalili E; Malysa A; Fratiloiu AR; Sloane BF; Porter LA
BMC Cancer; 2012 Jan; 12():45. PubMed ID: 22280365
[TBL] [Abstract][Full Text] [Related]
10. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.
McAndrew CW; Gastwirt RF; Donoghue DJ
Cell Cycle; 2009 Jan; 8(1):66-75. PubMed ID: 19106603
[TBL] [Abstract][Full Text] [Related]
11. Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.
Zhang L; Shen A; Ke Q; Zhao W; Yan M; Cheng C
J Mol Neurosci; 2012 Jul; 47(3):485-94. PubMed ID: 22447439
[TBL] [Abstract][Full Text] [Related]
12. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
[TBL] [Abstract][Full Text] [Related]
13. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
Gonzalez L; Nebreda AR
Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
[TBL] [Abstract][Full Text] [Related]
14. The atypical CDK activator RingoA/Spy1 regulates exit from quiescence in neural stem cells.
Gonzalez L; Domingo-Muelas A; Duart-Abadia P; Nuñez M; Mikolcevic P; Llonch E; Cubillos-Rojas M; Cánovas B; Forrow SMA; Morante-Redolat JM; Fariñas I; Nebreda AR
iScience; 2023 Mar; 26(3):106202. PubMed ID: 36876138
[TBL] [Abstract][Full Text] [Related]
15. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
[TBL] [Abstract][Full Text] [Related]
16. Spy1 expression prevents normal cellular responses to DNA damage: inhibition of apoptosis and checkpoint activation.
Gastwirt RF; Slavin DA; McAndrew CW; Donoghue DJ
J Biol Chem; 2006 Nov; 281(46):35425-35. PubMed ID: 16951407
[TBL] [Abstract][Full Text] [Related]
17. The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance.
Ferraiuolo RM; Tubman J; Sinha I; Hamm C; Porter LA
Oncotarget; 2017 Apr; 8(14):23337-23352. PubMed ID: 28423577
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of Cdk2-Speedy/Ringo A2.
Cheng A; Gerry S; Kaldis P; Solomon MJ
BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
[TBL] [Abstract][Full Text] [Related]
19. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
[TBL] [Abstract][Full Text] [Related]
20. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD
Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
